MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$466,233K
(13.36%↑ Y/Y)
Accounts receivable
$366,221K
(38.24%↑ Y/Y)
Inventory
$142,556K
(75.12%↑ Y/Y)
Prepaid and other
current assets
$38,303K
Restricted cash
$1,527K
(15.51%↑ Y/Y)
Total current assets
$1,014,840K
(28.63%↑ Y/Y)
Long-term inventory
$34,959K
(-53.83%↓ Y/Y)
Right-of-use assets
$18,195K
(13.13%↑ Y/Y)
Other assets
$5,555K
(311.79%↑ Y/Y)
Property and equipment,
net
$1,708K
(-42.14%↓ Y/Y)
Total assets
$1,075,257K
(21.49%↑ Y/Y)
Total liabilities and
stockholders equity
$1,075,257K
(21.49%↑ Y/Y)
Total liabilities
$705,110K
(7.40%↑ Y/Y)
Total stockholders
equity
$370,147K
(61.96%↑ Y/Y)
Accumulated deficit
-$3,012,978K
(0.74%↑ Y/Y)
Accumulated other
comprehensive loss
-$2,103K
(36.43%↑ Y/Y)
Long-term credit facility
$361,664K
(0.61%↑ Y/Y)
Total current
liabilities
$323,596K
(74.44%↑ Y/Y)
Lease liabilities
$11,947K
(17.12%↑ Y/Y)
Other liabilities
$7,903K
(-0.87%↓ Y/Y)
Additional paid-in capital
$3,385,216K
(3.61%↑ Y/Y)
Common stock, 0.0001
par value 200,000...
$12K
(0.00%↑ Y/Y)
Accrued expenses
$166,049K
(18.45%↑ Y/Y)
Convertible senior notes
$93,662K
(0.34%↑ Y/Y)
Accounts payable
$56,798K
(47.25%↑ Y/Y)
Current portion of lease
liabilities
$7,087K
(4.95%↑ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
APLS_BIG copy-svg
Apellis Pharmaceuticals, Inc. (APLS)
APLS_BIG copy-svg
Apellis Pharmaceuticals, Inc. (APLS)